CN1429613A - Colonitis enteroclysm - Google Patents
Colonitis enteroclysm Download PDFInfo
- Publication number
- CN1429613A CN1429613A CN03101319A CN03101319A CN1429613A CN 1429613 A CN1429613 A CN 1429613A CN 03101319 A CN03101319 A CN 03101319A CN 03101319 A CN03101319 A CN 03101319A CN 1429613 A CN1429613 A CN 1429613A
- Authority
- CN
- China
- Prior art keywords
- radix
- weight portion
- weight portions
- weight
- colitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
An enteroclysis for treating chronic colitis, chronic ulcerative colitis, chronic bacteria dysentery and amebic dysentery is prepared from 10 Chinese medicinal materials including agrimonia pilosa, Chinese pulsatilla root, phellodendron bark, flavescent sophora root, liquorice root, poppy capsule, etc. through extracting in water and/or alcohol.
Description
Technical field
The invention belongs to a kind of Chinese herbal medicine for external use prescription, particularly a kind of colitis enema.
Background technology
Chronic colitis is a commonly encountered diseases, and internal medicine does not still have the specific drug treatment at present.Treatment prescription about chronic colitis in the Chinese patent application bulletin has several, but great majority belong to oral formulations, wherein " enema treatment chronic colitis Chinese medicine preparation " (CN1176805) disclose a kind of with Pericarpium Granati, the Radix Stemonae, Galla Chinensis, the Radix Pulsatillae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Et Rhizoma Rhei, red paraffin wax, drug powders such as Alumen add that an amount of water and Amylum Nelumbinis Rhizomatis carry out the medicament of enema treatment, the Chinese patent Chinese patent medicine preparation and the preparation method of chronic colitis clinical syndrome " treatment " (CN1165008) disclose a kind of with Radix Sophorae Flavescentis, Folium Eucalypti Robustae, Indigo Naturalis, the enema that Margarita layer powder etc. are made, more than inorganic salts substances is all arranged in the prescription of two patent applications, still have many precipitate after particularly Indigo Naturalis is fried in shallow oil, some component for treating DeGrain, and in processing and the use inconvenience is arranged all.
Summary of the invention
The purpose of this invention is to provide a kind of evident in efficacy, using method simple, be the colitis enema of Main Ingredients and Appearance with pure medical herbs or its extract.
Purpose of the present invention realizes by following scheme:
A kind of colitis enema, it is made up of following raw materials according or is made up of as active ingredient the water and/or the alcohol extract of following raw materials according: Herba Agrimoniae 11-13 weight portion, Radix Pulsatillae 14-16 weight portion, Cortex Phellodendri 14-16 weight portion, Radix Arnebiae (Radix Lithospermi) 11-13 weight portion, Radix Sophorae Flavescentis 8-10 weight portion, Radix Rubiae 9-11 weight portion, Pericarpium Papaveris 2-4 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 14-16 weight portion, Fructus Chebulae 5-7 weight portion, Flos Caryophylli 2-4 weight portion.
The effect of each composition of the present invention is as follows:
Herba Agrimoniae: contain agrimonine, vitamin K etc., it can make clotting time shorten, and platelet increases, the treatment hemorrhage.To escherichia coli, bacillus pyocyaneus, dysentery bacterium, Bacillus typhi has inhibitory action.
The Radix Pulsatillae: contain Anemonin, analgesia, sedation are arranged, intestinal mucosa is had convergence, the antidiarrheal anastalsis, to amebic dysentery, bacillary dysentery and infusorian are all effective.
Cortex Phellodendri: contain yellow tiller alkali, antibacterial action and Rhizoma Coptidis are roughly the same.Ameba, fungus there are antibacterial action, blood sugar lowering, blood pressure and the effect of protection platelet are arranged.
Radix Arnebiae (Radix Lithospermi): analgesic, hypotensive effect is arranged, but anti-dermatophyte.Obvious anti-pituitary gonadotropic hormone and anti-chorionic-gonadotropin hormone effect are arranged.To chorionic epithelioma, women's menopause syndrome also has effect.
Radix Sophorae Flavescentis: contain matrine, antibacterial bacteriostatic is arranged, anticancer, strengthen effects such as body immunity.
Radix Rubiae: the effect of the clotting time of shortening is arranged, effective to the purple hall of anaphylaxis.Golden Portugal bacterium, Diplococcus pneumoniae there are inhibitory action, jaundice eliminating heat clearing away effect is arranged.
Pericarpium Papaveris: contain morphine, narcotine, codeine and papaverine etc., relieving diarrhea with astringents, analgesic effect are arranged.
The Pseudobulbus Bletillae (Rhizoma Bletillae): contain Pseudobulbus Bletillae (Rhizoma Bletillae) colloid, Glan Albert'stain Albert negative bacterium, tubercule bacillus are had inhibitory action, this product can make hemagglutination, forms artificial thrombosis, and haemostatic effect is determined rapidly.Endogenous toxin to some bacillus have inhibitory action.
Fructus Chebulae: contain and scold multitude's acid, tannin, fatty oil, oxidation gallic acid etc.Experiment in vitro has stronger bacteriostasis to diphtheria corynebacterium, dysentery bacterium, Diplococcus pneumoniae, bacillus pyocyaneus; Golden Portugal bacterium, Bacillus proteus, typhoid fever, Salmonella paratyphi also there are inhibitory action, and astriction is arranged.
Flos Caryophylli: contain caryophyllin, the volatilization wet goods.Staphylococcus aureus, diphtheria corynebacterium, Bacillus typhi, dysentery bacterium, anthrax bacillus etc. there are inhibitory action, can wriggle by stimulating gastrointestinal, impel gastric secretion.Pharmacological evaluation: it has antihistaminic, reduces capillary permeability, and the microcirculation improvement effect has convergence simultaneously, the repercussive effect.
Have the effect of sterilization detoxifcation, removing the necrotic tissue and promoting granulation, hemostasis antidiarrhea and analgesic after the above prescription combination, cure mainly chronic colitis, chronic ulcerative colitis, chronic bacillary dysentery and amebic dysentery.
The present invention press formula ratio decocting secondary in when treatment, and each extracting juice 200ml mixing divides sooner or later retention enema after each half temperature, gets buttocks and raises position, and the whole absorptions of medicinal liquid are not discharged, and 15 days is a course of treatment, and general treatment 2-3 course of treatment, per course of treatment, the interval was 3-5 days.
Therapeutic effect:
1. case is selected: divide treatment group and matched group, the treatment group is treated as stated above with the present invention, and matched group is given oral Berberine Tablet, norfloxacin or salazosulfamide sheet.
164 examples are organized in treatment, man's 85 examples, women 76 examples, age 18-72 year, average 48.2 years old, sick 1 year to 28.4 age, average 5.5 years, symptom has all repeatedly that lower abdomen is painful, abdominal distention, Mucous Stool or loose stool replace with constipation, and it is dissatisfied and go to a doctor often to take various western medicines in treatment curative effects, and all cases are used fibercolonscopy before treating, be diagnosed as chronic colitis, wherein chronic ulcerative colitis 54 examples, chronic non-ulcerative colitis 110 examples.
Matched group all through fibercolonscopy, is diagnosed as chronic colitis before all cases are treated by establishing 82 examples with the treatment group by 1: 2 randomized, ulcerative colitis 28 examples wherein, non-ulcerative colitis 54 examples.
2. therapeutic effect:
Curative effect determinate standard: a. cures: clinical symptom disappearance, and molding every day soft stool 1-2 time, the splanchnoscopy intestinal mucosa is normal.
B. produce effects: symptom is clearly better, and the splanchnoscopy extent of disease dwindles than originally more than 50% and (comprises 50%).
C. take a turn for the better: doing well,improving, the splanchnoscopy pathological changes is dwindled below 50%.
D. invalid: symptom does not have improvement, and splanchnoscopy does not have improvement.
After treatment, 164 examples are organized in treatment, cure 68 examples (41.46%), and wherein the ulcerative colitis cure rate reaches 64.8%, produce effects 42 examples (25.60%), 48 examples that take a turn for the better (29.26%), invalid 6 examples (3.65%); Total effective rate reaches 96.35%.
Matched group 82 examples, cure 11 examples (13.4%), wherein the ulcerative colitis cure rate 28.57%, produce effects 14 examples (17.07%), 37 examples that take a turn for the better (45.12%), invalid 20 examples (24.39%), total effective rate 75.60%, treatment group and matched group cure rate, total effective rate are added up and handled, utmost point significant difference is arranged.
Example surplus the clinical cure chronic colitis patient 1000 up to now.
The specific embodiment
Press routine prescription and prepare enema of the present invention: Herba Agrimoniae 12g, Radix Pulsatillae 15g, Cortex Phellodendri 15g, Radix Arnebiae (Radix Lithospermi) 12g, Radix Sophorae Flavescentis 9g, licorice 10g, Pericarpium Papaveris 3g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15g, Fructus Chebulae 6g, Flos Caryophylli 3g, after the pack auxiliary medicine, usage: each a bag, dissolve in 200 milliliters in the eliminating cold for resuscitation water, get buttocks and raise a retention enema, per 15 days is a course of treatment.
Make instant sugar free granule after also can enlarging by said ratio, it is for household use to be equipped with little enemator, and also available general infusion set is coloclysis within the family.
Claims (2)
1, a kind of colitis enema is characterized in that it is made up of following raw materials according or is made up of as active ingredient the water and/or the alcohol extract of following raw materials according: Herba Agrimoniae 11-13 weight portion, Radix Pulsatillae 14-16 weight portion, Cortex Phellodendri 14-16 weight portion, Radix Arnebiae (Radix Lithospermi) 11-13 weight portion, Radix Sophorae Flavescentis 8-10 weight portion, Radix Rubiae 9-11 weight portion, Pericarpium Papaveris 2-4 weight portion, Pseudobulbus Bletillae (Rhizoma Bletillae) 14-16 weight portion, Fructus Chebulae 5-7 weight portion, Flos Caryophylli 2-4 weight portion.
2, colitis enema as claimed in claim 1 is characterized in that the preferred proportioning of its component is: Herba Agrimoniae 12 weight portions, the Radix Pulsatillae 15 weight portions, Cortex Phellodendri 15 weight portions, Radix Arnebiae (Radix Lithospermi) 12 weight portions, Radix Sophorae Flavescentis 9 weight portions, licorice 10 weight portions, Pericarpium Papaveris 3 weight portions, the Pseudobulbus Bletillae (Rhizoma Bletillae) 15 weight portions, Fructus Chebulae's 6 weight portions, Flos Caryophylli 3 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031013198A CN1278727C (en) | 2003-01-02 | 2003-01-02 | Colonitis enteroclysm |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031013198A CN1278727C (en) | 2003-01-02 | 2003-01-02 | Colonitis enteroclysm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1429613A true CN1429613A (en) | 2003-07-16 |
| CN1278727C CN1278727C (en) | 2006-10-11 |
Family
ID=4789940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031013198A Expired - Fee Related CN1278727C (en) | 2003-01-02 | 2003-01-02 | Colonitis enteroclysm |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1278727C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104661669A (en) * | 2012-07-03 | 2015-05-27 | 庆熙大学校产学协力团 | Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases containing stemona root extract |
| CN105168399A (en) * | 2015-09-21 | 2015-12-23 | 青岛金智高新技术有限公司 | Clysis fluid for treating chronic non-specific ulcerative colitis |
| CN105535893A (en) * | 2015-12-31 | 2016-05-04 | 刘婵琳 | Traditional Chinese medicine enema for treating colonitis |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579825A (en) * | 2012-02-24 | 2012-07-18 | 北京市肛肠医院 | Compound hyacinth bletilla enema |
-
2003
- 2003-01-02 CN CNB031013198A patent/CN1278727C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104661669A (en) * | 2012-07-03 | 2015-05-27 | 庆熙大学校产学协力团 | Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases containing stemona root extract |
| CN105168399A (en) * | 2015-09-21 | 2015-12-23 | 青岛金智高新技术有限公司 | Clysis fluid for treating chronic non-specific ulcerative colitis |
| CN105535893A (en) * | 2015-12-31 | 2016-05-04 | 刘婵琳 | Traditional Chinese medicine enema for treating colonitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1278727C (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104127531A (en) | Traditional Chinese medicine composition for treating enterogastritis and preparation method thereof | |
| CN101422579B (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
| CN104096154A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN100444889C (en) | Chinese medicinal composition for treating mastopathy | |
| CN101306180A (en) | Gastropathy treating medicine | |
| CN101129872A (en) | Powder of phellodendron amurense adlay erysipelas | |
| CN1278727C (en) | Colonitis enteroclysm | |
| CN1318052C (en) | Medicine compositions for treating acne, and its prepn. method | |
| CN101322749A (en) | Chinese medicine oral liquid for treating wind-heat cold and preparation thereof | |
| CN104173977A (en) | Traditional Chinese medicine composition for stopping rhinorrhea, clearing heat and relieving fidgetiness in common cold and preparation method of traditional Chinese medicine composition | |
| CN102614324A (en) | Chinese medicinal synthetic preparation for assisting western medicines in treating phlebophlogosis | |
| KR20060033070A (en) | Hip-bath compositions for treatment of herorrhoids or gynecological diseases, and hip-bath bag containing it | |
| CN1059801C (en) | Medicament for treating rheum | |
| CN112022933B (en) | Pharmaceutical composition for treating stomachache with syndrome of qi stagnation and blood stasis | |
| CN1238012C (en) | Chinese medicine in the form of spray for treating infection of tonsil | |
| CN102846819A (en) | Chinese medicinal preparation for treating gestational coprostasis | |
| CN101129997A (en) | Oral liquid of curcuma aromatica for relieving exterior syndrome | |
| CN105326943A (en) | Pure traditional Chinese medicine for treating haemorrhoids | |
| CN108653460B (en) | Traditional Chinese medicine composition for treating chronic urticaria and preparation method thereof | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN101085185A (en) | Beverage containing white peony root and gardenia | |
| CN105031364A (en) | Preparation for preventing and treating toothache due to wind-fire evil and preparation method of preparation | |
| CN114796339A (en) | Traditional Chinese medicine composition for treating eczema and preparation method and application thereof | |
| CN105497267A (en) | Traditional Chinese medicine composition for treating extreme noxious heat type infantile jaundice | |
| CN1285371C (en) | Plant liquor for removing heat from lung to relieve cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061011 Termination date: 20100202 |